miRNA biomarkers to identify patients with pulmonary hypertension (PH), and sub-classify patients with pulmonary arterial hypertension (PAH) and chronic thromembolic PH (CTEPH)

miRNA biomarkers to identify patients with pulmonary hypertension (PH), and sub-classify patients with pulmonary arterial hypertension (PAH) and chronic thromembolic PH (CTEPH)
Innovative transducer designs and image reconstruction algorithms, enabling effective 3D/4D imaging in clinical practice
Novel lipid nanoparticles (LNPs) for targeted delivery of RNA-based vaccines and therapeutics, with improved long-term (12 months) thermostability at ambient temperatures (as high as 40 °C), in aqueous liquid or lyophilised form.
Novel heme oxygenase 1 (HO-1) probe compositions, and methods covering easy-to-use and rapid readouts of cell protection in cardiovascular diseases, hemorrhage and red cell disorders.
Topical use of Capsaicin or TRPV 1 agonists for the prevention of diabetic ulcers in a patient suffering from diabetic peripheral neuropathy (DPN).
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.